Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?

Understanding the mechanisms of HIV-1 transmission is crucial for the development of effective preventive microbicides and vaccine strategies, and remains one of the main goals of HIV research. Over the past decade, many studies have focused on trying to identify the 'gatekeeping' mechanism that restricts the transmission of CXCR4-utilizing HIV-1 more efficiently than CCR5-utilizing HIV-1. However, to date, no study has explained the almost perfect negative selection of the former in vivo. Here, we propose that there is no single gatekeeper and that, instead, the selective transmission of R5 HIV-1 depends on the superimposition of multiple imperfect gatekeepers.

[1]  A. Blauvelt,et al.  Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection , 1997, Nature Medicine.

[2]  Kees,et al.  Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. , 1994, The Journal of clinical investigation.

[3]  J. Kappes,et al.  Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells , 2002, Nature Medicine.

[4]  E. Ebert,et al.  Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation , 2000, Current Biology.

[5]  J. Zimmerberg,et al.  Infection of human tonsil histocultures: A model for HIV pathogenesis , 1995, Nature Medicine.

[6]  T. Ruckwardt,et al.  CXCR4-dependent HIV-1 infection of differentiated epithelial cells. , 2002, Virus research.

[7]  J. Lifson,et al.  Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. , 2004, Blood.

[8]  P. Tighe,et al.  HIV coreceptor and chemokine ligand gene expression in the male urethra and female cervix , 2005, AIDS.

[9]  F. Gotch,et al.  Chemokine receptor expression on mucosal dendritic cells from the endocervix of healthy women. , 2004, The Journal of infectious diseases.

[10]  A. Quayle,et al.  Immunological Microenvironments in the Human Vagina and Cervix: Mediators of Cellular Immunity Are Concentrated in the Cervical Transformation Zone1 , 2005, Biology of reproduction.

[11]  K. Auranen,et al.  Invasiveness of Serotypes and Clones of Streptococcus pneumoniae among Children in Finland , 2005, Infection and Immunity.

[12]  P. Watts,et al.  Parameters of Human Immunodeficiency Virus Infection of Human Cervical Tissue and Inhibition by Vaginal Virucides , 2000, Journal of Virology.

[13]  Friederike Hilbert,et al.  Conflicting needs for a Salmonella hypervirulence gene in host and non‐host environments , 2002, Molecular microbiology.

[14]  M. Bomsel.  Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier , 1997, Nature Medicine.

[15]  S. Buch,et al.  Selective transmission of R5-tropic HIV type 1 from dendritic cells to resting CD4+ T cells. , 2001, AIDS research and human retroviruses.

[16]  R. Koup,et al.  Infection of Specific Dendritic Cells by CCR5-Tropic Human Immunodeficiency Virus Type 1 Promotes Cell-Mediated Transmission of Virus Resistant to Broadly Neutralizing Antibodies , 2004, Journal of Virology.

[17]  M. Lederman,et al.  R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Waring,et al.  Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins , 2005, Nature Immunology.

[19]  Emmanuel Lagarde,et al.  Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial , 2005, PLoS medicine.

[20]  C. Cheng‐Mayer,et al.  CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Ho,et al.  Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. , 1998, Virology.

[22]  M. L. Penn,et al.  CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Grivel,et al.  CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue , 1999, Nature Medicine.

[24]  A. Blauvelt,et al.  HIV-infected human Langerhans cells transmit infection to human lymphoid tissue ex vivo , 2000, AIDS.

[25]  John P. Moore,et al.  Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor , 2005, Nature Medicine.

[26]  J. Reece,et al.  HIV-1 Selection by Epidermal Dendritic Cells during Transmission across Human Skin , 1998, The Journal of experimental medicine.

[27]  M. Lipsitch,et al.  Virulence and transmissibility of pathogens: what is the relationship? , 1997, Trends in microbiology.

[28]  I. Chen,et al.  A Preponderance of CCR5+CXCR4+ Mononuclear Cells Enhances Gastrointestinal Mucosal Susceptibility to Human Immunodeficiency Virus Type 1 Infection , 2001, Journal of Virology.

[29]  J. Collins,et al.  Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus‐type I , 2004, Immunology.

[30]  I. Keet,et al.  Lower prevalence and incidence of HIV‐1 syncytium‐inducing phenotype among injecting drug users compared with homosexual men , 1995, AIDS.

[31]  J. Tremaine,et al.  Complete nucleotide sequence of the cucumber necrosis virus genome. , 1989, Virology.

[32]  B. J. Hinnebusch,et al.  Flea-Borne Transmission Model To Evaluate Vaccine Efficacy against Naturally Acquired Bubonic Plague , 2004, Infection and Immunity.

[33]  M. Lederman,et al.  Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication , 2003 .

[34]  P. Earl,et al.  Cryptic Nature of a Conserved, CD4-Inducible V3 Loop Neutralization Epitope in the Native Envelope Glycoprotein Oligomer of CCR5-Restricted, but Not CXCR4-Using, Primary Human Immunodeficiency Virus Type 1 Strains , 2005, Journal of Virology.

[35]  W. Hanage,et al.  Using Multilocus Sequence Data To Define the Pneumococcus , 2005, Journal of bacteriology.

[36]  E. Fenyö,et al.  In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression , 1997, Nature Medicine.

[37]  M. Bomsel,et al.  Mucosal gatekeepers: Selecting HIV viruses for early infection , 2002, Nature Medicine.

[38]  J. Levy,et al.  Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation. , 2005, The Journal of general virology.

[39]  R. Blumenthal,et al.  Human β-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal Protection , 2005, Journal of Virology.

[40]  Anne Imberty,et al.  Heparan Sulfate Targets the HIV-1 Envelope Glycoprotein gp120 Coreceptor Binding Site* , 2005, Journal of Biological Chemistry.

[41]  C. Rousseau,et al.  Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. , 2004, The Journal of infectious diseases.

[42]  G. Shaw,et al.  Macrophage HIV‐1 infection and the gastrointestinal tract reservoir , 2003, Journal of leukocyte biology.

[43]  Simon C Watkins,et al.  Memory CD4+ T Cells Are the Earliest Detectable Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Cells in the Female Genital Mucosal Tissue during HIV-1 Transmission in an Organ Culture System , 2002, Journal of Virology.

[44]  L. Epstein,et al.  Interaction of HIV-1 and human salivary mucins. , 1994, Journal of acquired immune deficiency syndromes.

[45]  John P. Moore,et al.  The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. , 2004, AIDS research and human retroviruses.

[46]  G. Pantaleo,et al.  Transepithelial transport of HIV-1 by M cells is receptor-mediated , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Sodroski,et al.  Selective Interactions of Polyanions with Basic Surfaces on Human Immunodeficiency Virus Type 1 gp120 , 2000, Journal of Virology.

[48]  B. Spratt,et al.  Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. , 2003, The Journal of infectious diseases.

[49]  里見 操緒.  Transmission of macrophage-tropic HIV-1 by breast-milk macrophages via DC-SIGN , 2004 .

[50]  D. Richman,et al.  Semen-Specific Genetic Characteristics of Human Immunodeficiency Virus Type 1 env , 2005, Journal of Virology.

[51]  J. Albert,et al.  Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates , 1988, Journal of virology.

[52]  M. Fanger,et al.  Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. , 2004, The Journal of infectious diseases.

[53]  B. Walker,et al.  Human Immunodeficiency Virus Type 1 Populations in Blood and Semen , 1998, Journal of Virology.

[54]  Myron S. Cohen,et al.  The role of sexually transmitted diseases in HIV transmission , 2004, Nature Reviews Microbiology.

[55]  D. Musher,et al.  A brief history of the pneumococcus in biomedical research. , 1999, Seminars in respiratory infections.

[56]  D. Ho,et al.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.

[57]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[58]  Christopher J. Miller,et al.  Target cells in vaginal HIV transmission. , 2003, Microbes and infection.

[59]  E. Vicenzi,et al.  Envelope-Dependent Restriction of Human Immunodeficiency Virus Type 1 Spreading in CD4+ T Lymphocytes: R5 but Not X4 Viruses Replicate in the Absence of T-Cell Receptor Restimulation , 1999, Journal of Virology.

[60]  T. Geijtenbeek,et al.  DC-SIGN–mediated Infectious Synapse Formation Enhances X4 HIV-1 Transmission from Dendritic Cells to T Cells , 2004, The Journal of experimental medicine.

[61]  H. Schuitemaker,et al.  Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo. , 1996, Virology.

[62]  A. Haase.  Perils at mucosal front lines for HIV and SIV and their hosts , 2005, Nature Reviews Immunology.

[63]  H. Schuitemaker,et al.  Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis. , 1999, The Journal of infectious diseases.

[64]  A. Osterhaus,et al.  Macrophage Tropism of Human Immunodeficiency Virus Type 1 Facilitates In Vivo Escape from Cytotoxic T-Lymphocyte Pressure , 2001, Journal of Virology.

[65]  J. Sodroski,et al.  Oligomeric Modeling and Electrostatic Analysis of the gp120 Envelope Glycoprotein of Human Immunodeficiency Virus , 2000, Journal of Virology.

[66]  John P. Moore,et al.  Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus–cell fusion , 2005, Nature.

[67]  John P. Moore,et al.  Blockade of Attachment and Fusion Receptors Inhibits HIV-1 Infection of Human Cervical Tissue , 2004, The Journal of experimental medicine.

[68]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[69]  E. De Clercq,et al.  Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. , 1999, The Journal of clinical investigation.

[70]  Jeff F. Miller,et al.  Modulation of host immune responses, induction of apoptosis and inhibition of NF‐κB activation by the Bordetella type III secretion system , 2000, Molecular microbiology.

[71]  R. Connor,et al.  Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.

[72]  R. Koup,et al.  A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness. , 1998, The Journal of infectious diseases.

[73]  R. Bailey,et al.  Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. , 2002, The American journal of pathology.

[74]  Brouwer,et al.  Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1 , 2000, The Journal of clinical investigation.

[75]  J. Andersson,et al.  Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. , 1998, The American journal of pathology.

[76]  J. Church.  Massive Infection and Loss of Memory CD4+ T Cells in Multiple Tissues During Acute SIV Infection , 2006, Pediatrics.

[77]  G Vassart,et al.  Molecular cloning and functional expression of a new human CC-chemokine receptor gene. , 1996, Biochemistry.

[78]  C. Sabin,et al.  Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. , 1995 .

[79]  G. Scarlatti.  Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 , 2006 .

[80]  D. Baulcombe,et al.  An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. , 2003, The Plant journal : for cell and molecular biology.

[81]  M. Ostrowski,et al.  Both Memory and CD 45 RA 1 / CD 62 L 1 Naive CD 4 1 T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals , 1999 .